Table 1.
The main proteins and miRNAs having an effect on bone homeostasis are shown in the table as well as their putative function in this process and the corresponding references where this activity is described
MSC-EVs CARGO
| ||
Proteins
|
Bone healing functions
|
Ref.
|
MCP-1 | Induces angiogenesis and MSC recruitment to injury site | [107] |
MCP-3 | Promotes cell proliferation and MSC recruitment to injury site | [107] |
SDF-1 α | Recruits osteoprogenitor cells to wound area | [100] |
IL-6 | Induces endothelial/endothelial progenitor cell proliferation angiogenesis and osteogenesis | [107] |
FGF-2 | Fosters proliferation, differentiation and migration of vascular cells, chondrocytes and osteoblasts | [103,110,111] |
PDGF-B | Promotes mesenchymal proliferation, potentiates cartilage and intramembranous bone formation and stimulates angiogenic pathways | [100,103,114] |
VEGF | Promotes revascularization, regulation of vascular endothelial cell migration, proliferation, and capillary production, and improves the cellular activity of osteoblasts | [99] |
ANGPTL2 | Potentiates sprouting in endothelial cells | [114] |
Fibronectin | Collaborates in cell movement and migration and provides provisional fibers in cartilaginous matrices | [103] |
IGF-I | Induces collagen synthesis, reduces collagen degradation, promotes clonal expansion of chondrocytes and proliferation of preosteoblastic cells, and regulates migration of osteoblasts and MSCs | [103] |
TGF-β1 | Chemoattraction of macrophages, enhances migration, proliferation and differentiation of osteoprogenitor cells and cellular matrix production | [103,112,114] |
NRP1 | Induces endothelial cell migration and regulates other proangiogenic actions through the VEGF family and PDGFR | [113] |
microRNAs | Bone healing function | Ref. |
miR-10a | Improves mesenchymal stem cell differentiation capacity of hBM-MSCs and reduces cell senescence | [118] |
miR-10b | Increases in vitro migration of BM-MSCs | [119] |
miR-218, miR-92a and miR-199b | Enhance osteoblast differentiation of BM-MSCs | [120,122] |
miR-217 and miR-34 | Promote proliferation and osteoblast differentiation of BM-MSCs | [120,121] |
miR-375, miR-216a, let-7c and miR-22 | Stimulate osteogenic differentiation of hAD-MSCs | [124,125,127] |
miR-196a | Increases osteogenic differentiation of hAD-MSCs and osteogenic activity of osteoblasts | [106,126] |
miR-494 | Induces endothelial cell migration | [109] |
miR-129 and miR-136 | Promote endothelial cell proliferation | [129] |
miR-130a, miR-135b, let-7f and miR27b | Promote vascular tube formation | [117,130,132] |
miR-1246 | Enhances endothelial migration and tube formation | [131] |
miR-23a and miR-424 | Cause migration, proliferation and tube formation of endothelial cells | [133,134] |
miR-214 | Fosters prevention of cell senescence, migration and tube formation in endothelial cells, and RANKL-induced osteoclast differentiation in BMMs | [136,137] |
miR-148a | Stimulates osteoclastogenesis in early osteoclast progenitors | [138] |
miR-27a, miR-206, miR-29b, miR-181a and miR-302a | Induce osteogenic activity of osteoblasts | [106,139-141] |
miR-21 | Assists osteogenic differentiation, migration and senescence prevention in BM-MSCs; migration and proliferation of fibroblasts; migration, proliferation and ability to form endothelial tubes in endothelial cells; and RANKL-induced osteoclastogenesis in BMMs | [142-146] |
MSC: Mesenchymal stem cell; EVs: Extracellular vesicles; MCP: Monocyte chemotactic protein; SDF-1 α: Stromal cell-derived factor-1 α; IL-6: Interleukin-6; FGF-2: Fibroblast growth factor-2; VEGF: Vascular endothelial growth factor; ANGPTL: Angiopoietin-related protein; IGF: Insulin-like growth factor; TGF-β1: Transforming growth factor–β1; NRP1: Neuropilin 1; hAD: Human adipose; BM: Bone marrow; BMM: Bone marrow monocytes; RANKL: Receptor activator of nuclear factor kappa ligand.